HomeBUSINESS
BUSINESS

Opdivo-Yervoy Combo Filed in Japan for Melanoma
(Oct.2.2017)

Ono Pharmaceutical and Bristol-Myers Squibb said that their anti-PD-1 antibody Opdivo (nivolumab) was filed in Japan for its combination therapy with the anti-CTLA-4 antibody Yervoy (ipilimumab) for the treatment of melanoma ...
(LOG IN FOR FULL STORY)

News Calendar